Intriguingly, both studies indicate that the effects of MRE11 overexpression—although opposite from one another—are dependent on tumor location, underscoring the need for future studies aimed at elucidating the precise relationship between MRE11 expression, tumor location, and clinical outcomes in CRC. Here, MRE11 is linked to colorectal carcinoma.